Dexcom Adds Generative AI Platform to Its Over-the-Counter CGM

In a groundbreaking development, Dexcom has become the first medical device company to integrate generative AI into a continuous glucose monitor, revolutionizing the management of metabolic health. By embedding AI into its Stelo glucose monitor, Dexcom offers personalized, data-driven insights into glucose levels, diet, sleep, and lifestyle choices. This transformation empowers users to make informed, proactive health decisions, acting as a personalized “health coach”.

Dexcom's AI platform, powered by Google Cloud’s models, analyzes data from the Stelo biosensor, meal logs, and wearables to deliver tailored recommendations for better glucose control. The AI’s insights, such as suggesting a walk after a meal to counteract glucose spikes, are personalized to each user’s habits and preferences.

Intertek can support organizations in their attempts at integrating AI solutions like this through expert guidance and cutting-edge solutions. With its global expertise in testing, certification, and advisory services, Intertek ensures AI applications meet regulatory standards, enhance performance, and deliver impactful, safe, and secure solutions for the healthcare industry.

https://www.intertek.com/medical/ai-enabled-devices/